Form 4: Immatics N.V. Director Mathias Hothum Reports Stock Option Grant

Immatics N.V. Director Mathias Hothum has reported the acquisition of stock options, with vesting scheduled for June 16, 2026.

Summary

• Mathias Hothum, a Director at Immatics N.V., has filed a Form 4 statement detailing a transaction related to his beneficial ownership of the company's securities.
• The transaction involves the acquisition of 48,000 stock options with an exercise price of $9.09 per share.
• These options are set to vest fully on June 16, 2026, which is one year after the grant date.
• The filing also includes a Power of Attorney document authorizing specific individuals to act on behalf of Mathias Hothum for SEC filings.
• The Power of Attorney covers the submission of Forms 3, 4, and 5, as well as Form 144 filings related to potential sales of company stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on a standard stock option grant to a director, which is a routine event for executive compensation and does not inherently signal positive or negative company performance.

Positives

• Director Mathias Hothum has been granted stock options, indicating potential future equity ownership and alignment with company performance.
• The grant of 48,000 options suggests a level of confidence or incentive for the director.
• The existence of a Power of Attorney streamlines the reporting process for SEC filings, ensuring compliance.

Risks

• The value of the stock options is contingent on the future performance of Immatics N.V.'s stock price.
• There is a potential for future stock sales by the reporting person once options vest and are exercised, which could impact share supply.

Future Outlook

The stock options granted to Mathias Hothum will vest on June 16, 2026, at which point he will have the right to purchase 48,000 ordinary shares at an exercise price of $9.09 per share.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, including companies like Immatics N.V., to incentivize long-term performance and align executive interests with shareholder value. This type of compensation is standard for leadership roles in publicly traded companies focused on innovation and growth.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of options to a director is a standard compensation practice. The potential future exercise and sale of shares could impact share count and price, but this is a normal part of equity compensation.

Next Steps

• Vesting of 48,000 stock options on June 16, 2026.
• Potential exercise of stock options by Mathias Hothum after the vesting date.
• Potential filing of Form 144 for any subsequent sales of shares acquired through option exercise.

Key Dates

Keywords

Immatics N.V., IMTX, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing, Power of Attorney, Mathias Hothum